Allogene Therapeutics, Inc. (ALLO)

NASDAQ: ALLO · Real-Time Price · USD

2.780

+0.050 (1.83%)

At close: Feb 27, 2026, 4:00 PM EST

2.760

-0.020 (-0.72%)

After-hours: Feb 27, 2026, 7:55 PM EST

Allogene Therapeutics Market Cap

Allogene Therapeutics has a market cap or net worth of $624.75 million as of February 27, 2026. Its market cap has increased by 108.37% in one year.

Market Cap

624.75M

Enterprise Value

457.70M

1-Year Change

108.37%

Ranking

#2887

Market Cap Chart

Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.88B to $624.75M, a decrease of -78.31%. That is a compound annual growth rate of -18.69%.

Market Cap History

Date	Market Cap	% Change
Feb 27, 2026	624.75M	102.92%
Dec 31, 2025	307.88M	-31.06%
Dec 31, 2024	446.60M	-17.32%
Dec 29, 2023	540.17M	-40.45%
Dec 30, 2022	907.08M	-57.34%
Dec 31, 2021	2.13B	-39.95%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Alpha Tau Medical	661.65M
Vor Biopharma	641.07M
Replimune Group	631.68M
Rigel Pharmaceuticals	630.58M
Zura Bio	628.08M
Lexicon Pharmaceuticals	627.81M
Alto Neuroscience	611.70M
MeiraGTx Holdings	608.51M

Market Cap Rankings